Other Charges (Notes)

6 Months Ended

Jun. 30, 2013

Unusual or Infrequent Item [Line Items]

Unusual or Infrequent Items Disclosure [Text Block]

Other Charges

Other charges are summarized as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
Restructuring costs	$	—	$	4	$	—	$	4
Licensing dispute settlement	7		—		7		—
Costs related to mergers and acquisitions	5		—		5		5
Total other charges	$	12	$	4	$	12	$	9

Other costs of $7 were incurred during the second quarter of 2013 for the settlement of a licensing dispute associated with certain products.

Third party costs of $5 associated with merger and acquisition activity were incurred during the second quarter of 2013. Third party costs of $5 were incurred during the first quarter of 2012 related to the January 2012 acquisition of BioReliance and the March 2012 acquisition of Research Organics.

In the second quarter of 2012, the Company committed to a restructuring plan to exit various sales office locations in Europe. These exit activities impacted approximately 30 employees and were intended to further reduce the Company's fixed cost structure by streamlining the sales force in Europe. The total cost of this restructuring action was approximately $4.